HPV Testing in Men: Not Recommended for Routine Screening
No clinically validated HPV test exists for men, and routine HPV testing is not recommended for males. 1
Current Guideline Position
The CDC Sexually Transmitted Diseases Treatment Guidelines explicitly state that HPV tests should not be used to screen men 1. This recommendation is consistent across multiple guideline iterations and reflects several key clinical realities:
Why Testing Is Not Recommended
- No FDA-approved test exists for detecting HPV in men or in anatomical sites other than the cervix 2, 3
- No validated screening protocols have been established for the male population
- Clinical utility is limited because:
- Most HPV infections in men are asymptomatic and self-limited
- Testing does not change clinical management in immunocompetent men
- Partners in long-term relationships typically share HPV types regardless of testing results 1
What Can Be Detected Clinically
The most common manifestation of HPV infection in men is genital warts, which are diagnosed through visual clinical inspection rather than laboratory testing 1, 2. High-risk HPV types (those associated with cancer) seldom cause visible genital warts 1.
Special Populations: Exceptions to Consider
While routine screening is not recommended for immunocompetent heterosexual men, emerging evidence suggests potential benefit in specific high-risk groups 4:
Men Who Should Be Considered for Screening (When Resources Available)
- Men who have sex with men (MSM)
- HIV-positive men
For these populations, anal cytology screening may be considered in settings where appropriate follow-up with high-resolution anoscopy is available 4. This represents a departure from general recommendations due to the higher prevalence and persistence of HPV infection in these groups.
Clinical Counseling Points
When partners ask about HPV testing, provide these evidence-based messages 1, 5:
- Sex partners do not need to be tested for HPV 5
- Partners in ongoing relationships likely already share the same HPV types 1, 5
- HPV infection can remain dormant for years; detection does not indicate recent acquisition or infidelity 1
- Most sexually active adults will acquire HPV at some point; the immune system typically clears it without intervention 1
Research Context vs. Clinical Reality
Recent research studies have explored various sampling methods for HPV detection in men, including urine samples, genital swabs, and urethral swabs 6, 7. While these studies demonstrate technical feasibility (detection rates of 50-75% in research settings 6, 7), none of these methods have been validated for clinical use or approved by regulatory agencies 3.
The Gap Between Research and Practice
Multiple studies acknowledge that despite demonstrating utility in research contexts, no HPV test for men has received FDA approval 3. The 2020 comprehensive literature review concluded that while various detection methods exist, none have been approved for male screening despite potential applications 3.
Bottom Line for Clinical Practice
Do not order HPV testing for male patients unless they are part of a specialized high-risk screening program (MSM or HIV-positive with access to high-resolution anoscopy follow-up). Instead:
- Diagnose genital warts through visual inspection
- Focus on HPV vaccination for males aged 9-26 years (quadrivalent vaccine prevents genital warts) 1
- Counsel about condom use to reduce transmission risk, though condoms do not provide complete protection 1, 5
- Screen female partners according to standard cervical cancer screening guidelines 5
Common Pitfall to Avoid
Do not test male partners of women with positive HPV results. This provides no clinical benefit and may cause unnecessary anxiety 1, 5. The appropriate response is reassurance and education about HPV's ubiquity and natural history.